Orion is an innovative European R&D-based pharmaceuticals company employing more than 3,500 people in different countries. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.
Orion has sales companies and representative offices in more than 20 countries in Europe as well as in India and China. The company's head office is established in Espoo, Finland.
In countries where we do not have our own sales organisation, our partners play a key role in the sales and marketing of the company's products. These important markets include the United States and the Latin American countries. Collaboration is carried out widely also in the field of R&D in which Orion has built an international network of partners around its core therapy areas.
Read more about Orion Corporation.